Optimizing Drug Formulations for Successful First-in-Human Clinical Trials


Ensure a Smooth Transition from Formulation to Clinical Trials

Altasciences supports your formulation and drug development needs for preclinical safety testing, from discovery through first-in-human (FIH) clinical trials, for all dosage forms, such as oral liquids, powders, capsules, and injectables.

Our integrated approach combines formulation development, cGMP manufacturing and release testing, as well as clinical testing functions/workflows. One of the biggest benefits of this seamless offering is that our clinical trial teams work closely with the scientists involved in the formulation and manufacturing process, and are able to evaluate and optimize new formulations in the clinic, based on real-time human data. This collaboration and data sharing between our teams leads to shorter timelines, less risk, reduced costs, and improved flexibility.

Learn more about our expertise with both simple and complex formulation development, including those with highly potent APIs and solubility/bioavailability challenges. 

Scientific Journal Q&A Video

Altascientist issue 17 - First-in-Human

Video - Quick Chat with Andrew Buis


Questions? Speak with one of our experts.

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.